Females manifesting Becker muscular dystrophy (BMD) are even more rarely observed than for the allelic condition Duchenne muscular dystrophy. The male proband has typical BMD with greatly raised CK activity and a myopathic muscle biopsy. His mother experienced walking difficulties from 35 years of age and has a myopathy with marked calf hypertrophy, a raised CK, and a myopathic muscle biopsy. Dystrophin analysis was undertaken on both the proband and his mother. Immunoblotting showed a protein of normal size but of reduced abundance in both. Immunocytochemical analysis in the proband indicated that the majority of the fibres showed weak dystrophin labelling and in his mother both dystrophin positive and dystrophin negative fibres were present. Non-random X inactivation at locus DXS255, was observed in DNA isolated from peripheral lymphocytes of the mother. Neither extended multiplex PCR performed on DNA from the proband nor analysis of lymphocyte derived mRNA showed a structural alteration in the dystrophin gene suggesting that an unusual mutation was responsible for BMD in this family.
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Becker muscular dystrophy (BMD) has usually been thought of as an uncommon Xp2l1 muscular dystrophy in comparison to the allelic condition Duchenne muscular dystrophy (DMD) based on studies that predate isolation of the dystrophin gene.' However, recent estimates suggest that BMD is more common than previously appreciated.2 The disease is characterised in affected males by a slowly progressive proximal myopathy and BMD is a milder condition and has a more variable phenotype than DMD, with an age of onset in BMD that varies from early childhood to the second decade or later.3 Patients with BMD may experience great variation in disability as evidenced by the wide age range at which they become chairbound, but a substantial proportion of subjects never require a wheelchair and have normal longevity. This heterogeneous expression of BMD shows great variability even within families.'
Females clinically manifesting X linked recessive diseases are well documented. This can be as a consequence of Turner's syndrome or as the result of a structural rearrangement of an X chromosome leading to inactivation of the normal X (as in an X;autosome translocation). In addition the manifestation in females who are chromosomally normal is presumed to occur as the result of non-random X inactivation which produces a preponderance of cells with a defective X chromosome active.4 All three explanations have been invoked to explain females manifesting DMD.5 However, only a few reports exist of females manifesting BMD, ascertained after the diagnosis of BMD in an index male case, in any form other than anecdotes of marginal weakness.9
We report a severely affected female with BMD in conjunction with the results of the investigation of the dystrophin gene and related aspects in this family.
Case report
The family whose pedigree is depicted in fig 1 was referred to the genetic counselling service because of concern related to the risk posed to other members of the family, in particular III-2 and IV 1. The proband had symptoms from early childhood. Upright walking was noted at 14 months of age but there was concern from 4 years of age because of leg pains, inability to run, and difficulty in negotiating stairs. 16 A monoclonal antibody which recognises 1 spectrin in skeletal muscle (RBC2/3D5) was also used in this investigation.
The results of the immunocytochemical labelling with Dy8/6C5 are depicted in figs 2 and 3. Despite only a few residual muscle fibres being present in the biopsy obtained from the proband (fig 2) , dystrophin labelling is distinctly reduced confirming an Xp2l muscular dystrophy. In the mother, H&E staining indicates non-specific variability in fibre size and immunolabelling showed a pattern of dystrophin positive, dystrophin negative fibres and partially labelled fibres confirming her as a carrier of an Xp2l muscular dystrophy (fig 3) . The proportion of fibres showing a total absence of labelling was 23%, partial labelling was seen on 30%, and continuous labelling on 47% (estimated on a sample of 500 fibres).
The result of an immunoblot labelled with Dy8/6C5 is depicted in the western blot of fig 4. This shows that the proband and his mother have a normal sized dystrophin molecule of approximately 400 kd when compared to that of simultaneously loaded controls. Densitometric analysis was carried out on the dystrophin and myosin bands as outlined elsewhere.'5 The abundance of dystrophin (for the carboxy-terminus) was reduced, estimated to be 68% for the proband and 35% for his mother when allowance was made for the amount of 'muscle protein' extracted from the sample.
In order to study the pattern of X inactivation DNA was extracted from peripheral lymphocytes of the mother and digested with MspI and its isoschizomer HpaII. Both reactions were codigested with BamHI. The Southern blot was hybridised with the DNA probe M271 which detects the methylation sensitive locus DXS255 at Xpl 1.22. The results are depicted in fig 5. It is apparent that non-random X inactivation in this tissue is present and that the X chromosome that the proband has inherited is preferentially active in his mother. Discussion A rigorous survey to estimate BMD and DMD frequencies by using cDNA probes and dystrophin immunolabelling enabled, particularly for sporadic cases, a high proportion of definitive diagnoses to be achieved.2 This survey reported the highest incidence (1/18 450 births) and prevalence (2 38/100 000) of BMD yet recorded. The ratio of BMD to DMD is also the highest observed although it was noted that the incidence of DMD had declined in recent years.2 The commonest revision of diagnoses were males labelled as having 'limbgirdle' dystrophy or spinal muscular atrophy. After a request for genetic counselling it was decided to reinvestigate this family using newly available dystrophin technology. This was undertaken because of the unusual clinical picture observed in the mother, notably the marked distal involvement. An additional reason to review the diagnosis in this family was provided by the apparent lack of a deletion in the dystrophin gene of the proband, which is in contrast to the usual finding in BMD males who typically have an identifiable deletion in C. their dystrophin gene.'7 18 A diagnosis of BMD in this family was confirmed by the dystrophin analysis. Western blot analysis showed a reduced amount of normal sized dystrophin molecules.
In the absence of Turner's syndrome or a structural abnormality of the X chromosome, Lyonisation may be invoked to explain the manifestation of Xp2l muscular dystrophy in heterozygotes. The findings of skewed X inactivation in the peripheral blood of the monozygotic twins discordant for DMD supported the involvement of this mechanism and suggested an influence in determining the twinning process.' Females manifesting X linked conditions would be expected by statistical dictates '9 alone, but good evidence exists for familial aggregation of manifesting DMD heterozygotes7 suggesting that either environmental factors are important or that the process of Figure 5 Autoradiograph after hybrd to MspI/BamHI, and HpaII/BamHI i from the proband and his mother. The j shows that the mother is heterozygous a locus detected by M27f. In her HpaII deficiency of the 10 kb band indicating X chromosome represented by this allele is active in the mother and that X inactiv non-random.
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